{"id":"W4367047605","doi":"10.1001/jamanetworkopen.2023.10039","title":"Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19","year":2023,"lang":"en","type":"article","venue":"JAMA Network Open","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Center for Advancing Translational Sciences; AstraZeneca","keywords":"Coronavirus disease 2019 (COVID-19); Medicine; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Virology; Internal medicine; Outbreak","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001236254,0.000250463,0.0007926103,0.0001895572,0.0001237735,0.0001686831,0.0003529848,0.0002184125,0.00003684791],"category_scores_gemma":[0.000874979,0.000182005,0.00004447059,0.001183377,0.0002422648,0.0002129124,0.0005656946,0.0004218949,0.00001213475],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001242146,"about_ca_system_score_gemma":0.0006657811,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006193828,"about_ca_topic_score_gemma":0.00036151,"domain_scores_codex":[0.9976914,0.0002241723,0.000545267,0.0005356936,0.0004648941,0.0005386012],"domain_scores_gemma":[0.9983174,0.0007199126,0.0001573772,0.0004811556,0.0001391437,0.0001850082],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06431836,0.0008894947,0.8942974,0.0006107542,0.000309056,0.0005848419,0.002590998,0.00001227705,0.00009566637,0.0002636876,0.001427537,0.03459993],"study_design_scores_gemma":[0.05827277,0.004632833,0.9077784,0.000650622,0.00009981154,0.00002343389,0.0003496941,0.0007253828,0.00008647031,0.0001520145,0.02690767,0.0003208449],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939005,0.0001696533,0.00006365885,0.001743916,0.00005541537,0.002893186,0.00002518113,0.00005482969,0.001093594],"genre_scores_gemma":[0.9867369,0.00006005318,0.0004272944,0.01239592,0.00007074373,0.00009259944,0.00007701266,0.0000504373,0.00008905923],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03427908,"threshold_uncertainty_score":0.7421949,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03367806491160733,"score_gpt":0.3402387068771673,"score_spread":0.3065606419655599,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}